Literature DB >> 7702112

The economic value of contraception: a comparison of 15 methods.

J Trussell1, J A Leveque, J D Koenig, R London, S Borden, J Henneberry, K D LaGuardia, F Stewart, T G Wilson, S Wysocki.   

Abstract

OBJECTIVES: The purpose of the study was to determine the clinical and economic impact of alternative contraceptive methods.
METHODS: Direct medical costs (method use, side effects, and unintended pregnancies) associated with 15 contraceptive methods were modeled from the perspectives of a private payer and a publicly funded program. Cost data were drawn from a national claims database and MediCal. The main outcome measures included 1-year and 5-year costs and number of pregnancies avoided compared with use of no contraceptive method.
RESULTS: All 15 contraceptives were more effective and less costly than no method. Over 5 years, the copper-T IUD, vasectomy, the contraceptive implant, and the injectable contraceptive were the most cost-effective, saving $14,122, $13,899, $13,813, and $13,373, respectively, and preventing approximately the same number of pregnancies (4.2) per person. Because of their high failure rates, barrier methods, spermicides, withdrawal, and periodic abstinence were costly but still saved from $8933 to $12,239 over 5 years. Oral contraceptives fell between these groups, costing $1784 over 5 years, saving $12,879, and preventing 4.1 pregnancies.
CONCLUSIONS: Contraceptives save health care resources by preventing unintended pregnancies. Up-front acquisition costs are inaccurate predictors of the total economic costs of competing contraceptive methods.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702112      PMCID: PMC1615115          DOI: 10.2105/ajph.85.4.494

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies.

Authors:  J Trussell; F Stewart; F Guest; R A Hatcher
Journal:  Fam Plann Perspect       Date:  1992 Nov-Dec

2.  The effectiveness of postcoital hormonal contraception.

Authors:  J Trussell; F Stewart
Journal:  Fam Plann Perspect       Date:  1992 Nov-Dec

3.  The sexual and reproductive behavior of American women, 1982-1988.

Authors:  J D Forrest; S Singh
Journal:  Fam Plann Perspect       Date:  1990 Sep-Oct

4.  Efficacy of the simultaneous use of condoms and spermicides.

Authors:  P Kestelman; J Trussell
Journal:  Fam Plann Perspect       Date:  1991 Sep-Oct

5.  Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.

Authors:  A L Hillman; J M Eisenberg; M V Pauly; B S Bloom; H Glick; B Kinosian; J S Schwartz
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

6.  Long-acting, more effective copper T IUDs: a summary of U.S. experience, 1970-75.

Authors:  I Sivin; J Stern
Journal:  Stud Fam Plann       Date:  1979-10

7.  Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.

Authors:  D B Petitti; D Porterfield
Journal:  Contraception       Date:  1992-02       Impact factor: 3.375

8.  The accessibility of abortion services in the United States.

Authors:  S K Henshaw
Journal:  Fam Plann Perspect       Date:  1991 Nov-Dec

9.  International experience with NORPLANT and NORPLANT-2 contraceptives.

Authors:  I Sivin
Journal:  Stud Fam Plann       Date:  1988 Mar-Apr

10.  Tubal sterilization: findings in a large prospective study.

Authors:  M Vessey; G Huggins; M Lawless; K McPherson; D Yeates
Journal:  Br J Obstet Gynaecol       Date:  1983-03
View more
  32 in total

1.  Economic analysis of long-term reversible contraceptives. Focus on Implanon.

Authors:  C J Phillips
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Modeling the cost and outcomes of pharmacist-prescribed emergency contraception.

Authors:  K D Marciante; J S Gardner; D L Veenstra; S D Sullivan
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

3.  Health authority commissioning for quality in contraception services.

Authors:  M Newman; M Bardsley; D Morgan; B Jacobson
Journal:  Qual Health Care       Date:  1998-09

Review 4.  Preventing unintended teenage pregnancies and reducing their adverse effects.

Authors:  D Fullerton; R Dickson; A J Eastwood; T A Sheldon
Journal:  Qual Health Care       Date:  1997-06

5.  Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides.

Authors:  I N Batova; R T Richardson; E E Widgren; M G O'Rand
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

6.  How safe is emergency contraception?

Authors:  Abigail Norris Turner; Charlotte Ellertson
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception.

Authors:  J Trussell; J Koenig; C Ellertson; F Stewart
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

9.  Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.

Authors:  David Hubacher; Hannah Spector; Charles Monteith; Pai-Lien Chen; Catherine Hart
Journal:  Am J Obstet Gynecol       Date:  2016-09-20       Impact factor: 8.661

10.  Norplant selection and satisfaction among low-income women.

Authors:  L L Clarke; K Schmitt; C A Bono; J Steele; M K Miller
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.